DOPATREEPreview
Open in TheBrain

US FDA. GUIDANCE. THE 510(K) PROGRAM : EVALUATING SUBSTANTIAL EQUIVALENCE IN PREMARKET NOTIFICATIONS. JUL 28, 2014.

Attachments